ABZELECTPRO Trademark

Trademark Overview


On Monday, July 22, 2024, a trademark application was filed for ABZELECTPRO with the United States Patent and Trademark Office. The USPTO has given the ABZELECTPRO trademark a serial number of 98660697. The federal status of this trademark filing is FINAL REFUSAL - MAILED as of Thursday, May 29, 2025. This trademark is owned by Abzena (UK) Limited. The ABZELECTPRO trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical compositions, namely, cell lines, cell cultures, antibodies and proteins for use in the development and manufacture of pharmaceutical preparations and vaccines; pharmaceutical preparations for the treatment of viral diseases and disorders, immune diseases and disorders, respiratory diseases and disorders, microbial infections and diseases, cancer, haematological diseases and disorders, gastro-intestinal diseases and disorders, inflammation, arthritis, hepatitis, anemia, coagulation diseases and disorders, pain, obesity, and diabetes; vaccines; pharmaceutical preparations for skin care; none of the aforementioned products being finished pharmaceutical products administered to patients for the treatment of Parkinson's disease or other diseases or disorders of the central nervous system

Chemical preparations for use in the manufacture of pharmaceuticals; chemicals for use in the pharmaceutical industry; preservatives for use in the pharmaceutical industry; chemical additives for use in the manufacture of pharmaceuticals, namely, flavor improvers; additives for use in the manufacture of pharmaceuticals, namely, cell lines, antibodies, and proteins for use as intermediates for pharmaceuticals

Scientific and technological services, namely, scientific research in the field of cell lines, cell cultures, proteins, and antibodies for use in the development and manufacture of vaccines and pharmaceutical preparations; industrial analysis and research in the field of cell lines, cell cultures, proteins, and antibodies for use in the development and manufacture of vaccines and pharmaceutical preparations; new product design services; pharmaceutical research services; pharmaceutical product evaluation; inspection of pharmaceuticals; testing of pharmaceuticals; pharmaceutical drug development services; development of pharmaceutical preparations and medicines; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; provision of scientific information in the field of vaccines, pharmaceuticals, and in the field of cell lines, proteins, and antibodies for use in the manufacture and development of pharmaceuticals and vaccines; provision of...
abzelectpro

General Information


Serial Number98660697
Word MarkABZELECTPRO
Filing DateMonday, July 22, 2024
Status645 - FINAL REFUSAL - MAILED
Status DateThursday, May 29, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical compositions, namely, cell lines, cell cultures, antibodies and proteins for use in the development and manufacture of pharmaceutical preparations and vaccines; pharmaceutical preparations for the treatment of viral diseases and disorders, immune diseases and disorders, respiratory diseases and disorders, microbial infections and diseases, cancer, haematological diseases and disorders, gastro-intestinal diseases and disorders, inflammation, arthritis, hepatitis, anemia, coagulation diseases and disorders, pain, obesity, and diabetes; vaccines; pharmaceutical preparations for skin care; none of the aforementioned products being finished pharmaceutical products administered to patients for the treatment of Parkinson's disease or other diseases or disorders of the central nervous system
Goods and ServicesChemical preparations for use in the manufacture of pharmaceuticals; chemicals for use in the pharmaceutical industry; preservatives for use in the pharmaceutical industry; chemical additives for use in the manufacture of pharmaceuticals, namely, flavor improvers; additives for use in the manufacture of pharmaceuticals, namely, cell lines, antibodies, and proteins for use as intermediates for pharmaceuticals
Goods and ServicesScientific and technological services, namely, scientific research in the field of cell lines, cell cultures, proteins, and antibodies for use in the development and manufacture of vaccines and pharmaceutical preparations; industrial analysis and research in the field of cell lines, cell cultures, proteins, and antibodies for use in the development and manufacture of vaccines and pharmaceutical preparations; new product design services; pharmaceutical research services; pharmaceutical product evaluation; inspection of pharmaceuticals; testing of pharmaceuticals; pharmaceutical drug development services; development of pharmaceutical preparations and medicines; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; provision of scientific information in the field of vaccines, pharmaceuticals, and in the field of cell lines, proteins, and antibodies for use in the manufacture and development of pharmaceuticals and vaccines; provision of toxicological research information; toxicology research services, namely, assessing toxicological information in relation to risks; chemical research, namely, assessing chemical information in relation to risks; none of the aforementioned services relating to finished pharmaceutical products administered to patients for the treatment of Parkinson's disease or other diseases or disorders of the central nervous system

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateMonday, July 22, 2024
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, July 22, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, July 22, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAbzena (UK) Limited
Party Type10 - Original Applicant
Legal Entity Type24 - NOT AVAILABLE
AddressBabraham, Cambridge CB223AT
GB

Trademark Events


Event DateEvent Description
Wednesday, January 15, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 23, 2025TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Thursday, January 23, 2025TEAS VOLUNTARY AMENDMENT RECEIVED
Monday, July 22, 2024NEW APPLICATION ENTERED
Thursday, January 30, 2025ASSIGNED TO EXAMINER
Monday, February 3, 2025NON-FINAL ACTION WRITTEN
Monday, February 3, 2025NON-FINAL ACTION E-MAILED
Monday, February 3, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 23, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 23, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 23, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 29, 2025FINAL REFUSAL WRITTEN
Thursday, May 29, 2025NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, May 29, 2025FINAL REFUSAL E-MAILED